Drug Shortage Report for PMS-EPIRUBICIN
Report ID | 83663 |
Drug Identification Number | 02410400 |
Brand name | PMS-EPIRUBICIN |
Common or Proper name | EPIRUBICIN |
Company Name | PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | EPIRUBICIN HYDROCHLORIDE |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5ml |
ATC code | L01DB |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-07-30 |
Estimated end date | Unknown |
Actual end date | 2019-09-02 |
Shortage status | Resolved |
Updated date | 2019-09-03 |
Company comments | Please see discontinued report # 87934 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-09-03 | French | Compare |
v5 | 2019-09-03 | English | Compare |
v4 | 2019-07-31 | French | Compare |
v3 | 2019-07-31 | English | Compare |
v2 | 2019-05-09 | French | Compare |
v1 | 2019-05-09 | English | Compare |
Showing 1 to 6 of 6